Finding better ways to combat resistant gram-negative bacterial infections remains an ongoing challenge for health care practitioners and researchers alike. One way ARLG’s Gram-Negative Committee meets this challenge is by regularly reviewing and implementing innovative, early-stage study ideas.
Currently, the committee is seeking interventional study ideas that aim to fill the most critical knowledge gaps and have the largest impact on clinical practice. All ideas are welcome, but some areas of interest include the optimum therapy (agents, dose, duration, interval, type of administration, clinical algorithms) and its impact on efficacy, clinical outcomes, and prevention of resistance.
Synopses should be no more than a half page (250 words) in length. The deadline for idea submissions is March 31.